The interferon (IFN) system is an extremely powerful antiviral response that is capable of controlling most, if not all, virus infections in the absence of adaptive immunity. However, viruses can still replicate and cause disease in vivo, because they have some strategy for at least partially circumventing the IFN response. We reviewed this topic in 2000 [Goodbourn, S., Didcock, L. & Randall, R. E. (2000). J Gen Virol81, 2341–2364] but, since then, a great deal has been discovered about the molecular mechanisms of the IFN response and how different viruses circumvent it. This information is of fundamental interest, but may also have practical application in the design and manufacture of attenuated virus vaccines and the development of novel antiviral drugs. In the first part of this review, we describe how viruses activate the IFN system, how IFNs induce transcription of their target genes and the mechanism of action of IFN-induced proteins with antiviral action. In the second part, we describe how viruses circumvent the IFN response. Here, we reflect upon possible consequences for both the virus and host of the different strategies that viruses have evolved and discuss whether certain viruses have exploited the IFN response to modulate their life cycle (e.g. to establish and maintain persistent/latent infections), whether perturbation of the IFN response by persistent infections can lead to chronic disease, and the importance of the IFN system as a species barrier to virus infections. Lastly, we briefly describe applied aspects that arise from an increase in our knowledge in this area, including vaccine design and manufacture, the development of novel antiviral drugs and the use of IFN-sensitive oncolytic viruses in the treatment of cancer.
AhmedM.,
LylesD. S.1998; Effect of vesicular stomatitis virus matrix protein on transcription directed by host RNA polymerases I, II, and III. J Virol 72:8413–8419
AhmedM.,
McKenzieM. O.,
PuckettS.,
HojnackiM.,
PoliquinL.,
LylesD. S.2003; Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis. J Virol 77:4646–4657[CrossRef]
AhnJ. H.,
HaywardG. S.2000; Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection. Virology 274:39–55[CrossRef]
AlcamiA.,
SymonsJ. A.,
SmithG. L.2000; The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol 74:11230–11239[CrossRef]
AlexopoulouL.,
HoltA. C.,
MedzhitovR.,
FlavellR. A.2001; Recognition of double-stranded RNA and activation of NF- κ B by Toll-like receptor 3. Nature 413:732–738[CrossRef]
AndrejevaJ.,
YoungD. F.,
GoodbournS.,
RandallR. E.2002a; Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons. J Virol 76:2159–2167[CrossRef]
AndrejevaJ.,
PooleE.,
YoungD. F.,
GoodbournS.,
RandallR. E.2002b; The p127 subunit (DDB1) of the UV-DNA damage repair binding protein is essential for the targeted degradation of STAT1 by the V protein of the paramyxovirus simian virus 5. J Virol 76:11379–11386[CrossRef]
AndrejevaJ.,
ChildsK. S.,
YoungD. F.,
CarlosT. S.,
StockN.,
GoodbournS.,
RandallR. E.2004; The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN- β promoter. Proc Natl Acad Sci U S A 101:17264–17269[CrossRef]
AnkelH.,
WestraD. F.,
Welling-WesterS.,
LebonP.1998; Induction of interferon- α by glycoprotein D of herpes simplex virus: a possible role of chemokine receptors. Virology 251:317–326[CrossRef]
AntonssonA.,
PayneE.,
HengstK.,
McMillanN. A.2006; The human papillomavirus type 16 E7 protein binds human interferon regulatory factor-9 via a novel PEST domain required for transformation. J Interferon Cytokine Res 26:455–461[CrossRef]
ArgyrisE. G.,
AcheampongE.,
WangF.,
HuangJ.,
ChenK.,
MukhtarM.,
ZhangH.2007; The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system. Virology 367:440–451[CrossRef]
AsefaB.,
KlarmannK. D.,
CopelandN. G.,
GilbertD. J.,
JenkinsN. A.,
KellerJ. R.2004; The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation. Blood Cells Mol Dis 32:155–167[CrossRef]
AuW. C.,
MooreP. A.,
LaFleurD. W.,
TombalB.,
PithaP. M.1998; Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J Biol Chem 273:29210–29217[CrossRef]
BalachandranS.,
KimC. N.,
YehW. C.,
MakT. W.,
BhallaK.,
BarberG. N.1998; Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling. EMBO J 17:6888–6902[CrossRef]
BalachandranS.,
RobertsP. C.,
BrownL. E.,
TruongH.,
PattnaikA. K.,
ArcherD. R.,
BarberG. N.2000a; Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13:129–141[CrossRef]
BalachandranS.,
RobertsP. C.,
KippermanT.,
BhallaK. N.,
CompansR. W.,
ArcherD. R.,
BarberG. N.2000b; Alpha/beta interferons potentiate virus-induced apoptosis through activation of the FADD/caspase-8 death signaling pathway. J Virol 74:1513–1523[CrossRef]
BarnardP.,
PayneE.,
McMillanN. A.2000; The human papillomavirus E7 protein is able to inhibit the antiviral and anti-growth functions of interferon- α . Virology 277:411–419[CrossRef]
BarnesB. J.,
RichardsJ.,
ManclM.,
HanashS.,
BerettaL.,
PithaP. M.2004; Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem 279:45194–45207[CrossRef]
BarroM.,
PattonJ. T.2007; Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7. J Virol 81:4473–4481[CrossRef]
BartlettE. J.,
Amaro-CarambotE.,
SurmanS. R.,
CollinsP. L.,
MurphyB. R.,
SkiadopoulosM. H.2006; Introducing point and deletion mutations into the P/C gene of human parainfluenza virus type 1 (HPIV1) by reverse genetics generates attenuated and efficacious vaccine candidates. Vaccine 24:2674–2684[CrossRef]
BasleM. F.,
RussellW. C.,
GoswamiK. K.,
RebelA.,
GiraudonP.,
WildF.,
FilmonR.1985; Paramyxovirus antigens in osteoclasts from Paget's bone tissue detected by monoclonal antibodies. J Gen Virol 66:2103–2110[CrossRef]
BasleM. F.,
FournierJ. G.,
RozenblattS.,
RebelA.,
BouteilleM.1986; Measles virus RNA detected in Paget's disease bone tissue by in situ hybridization. J Gen Virol 67:907–913[CrossRef]
BasleM. F.,
RebelA.,
FournierJ. G.,
RussellW. C.,
MalkaniK.1987; On the trail of paramyxoviruses in Paget's disease of bone. Clin Orthop Relat Res 217:9–15
BauhoferO.,
SummerfieldA.,
McCulloughK. C.,
RuggliN.2005; Role of double-stranded RNA and Npro of classical swine fever virus in the activation of monocyte-derived dendritic cells. Virology 343:93–105[CrossRef]
BauhoferO.,
SummerfieldA.,
SakodaY.,
TratschinJ. D.,
HofmannM. A.,
RuggliN.2007; Npro of classical swine fever virus interacts with interferon regulatory factor 3 and induces its proteasomal degradation. J Virol 81:3087–3096[CrossRef]
BaumertT. F.,
RoslerC.,
MalimM. H.,
von WeizsackerF.2007; Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C. Hepatology 46:682–689
BelovG. A.,
LidskyP. V.,
MikitasO. V.,
EggerD.,
LukyanovK. A.,
BienzK.,
AgolV. I.2004; Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores. J Virol 78:10166–10177[CrossRef]
BergeronJ.,
MabroukT.,
GarzonS.,
LemayG.1998; Characterization of the thermosensitive ts453 reovirus mutant: increased dsRNA binding of ς3 protein correlates with interferon resistance. Virology 246:199–210[CrossRef]
BerkowitzB.,
HuangD. B.,
Chen-ParkF. E.,
SiglerP. B.,
GhoshG.2002; The x-ray crystal structure of the NF- κ B p50.p65 heterodimer bound to the interferon β -κ B site. J Biol Chem 277:24694–24700[CrossRef]
BestS. M.,
MorrisK. L.,
ShannonJ. G.,
RobertsonS. J.,
MitzelD. N.,
ParkG. S.,
BoerE.,
WolfinbargerJ. B.,
BloomM. E.2005; Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol 79:12828–12839[CrossRef]
BillecocqA.,
SpiegelM.,
VialatP.,
KohlA.,
WeberF.,
BouloyM.,
HallerO.2004; NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J Virol 78:9798–9806[CrossRef]
BlakqoriG.,
DelhayeS.,
HabjanM.,
BlairC. D.,
Sanchez-VargasI.,
OlsonK. E.,
Attarzadeh-YazdiG.,
FragkoudisR.,
KohlA.other authors2007; La Crosse bunyavirus nonstructural protein NSs serves to suppress the type I interferon system of mammalian hosts. J Virol 81:4991–4999[CrossRef]
BlondelD.,
RegadT.,
PoissonN.,
PavieB.,
HarperF.,
PandolfiP. P.,
De TheH.,
Chelbi-AlixM. K.2002; Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 21:7957–7970[CrossRef]
BluyssenH. A.,
LevyD. E.1997; Stat2 is a transcriptional activator that requires sequence-specific contacts provided by stat1 and p48 for stable interaction with DNA. J Biol Chem 272:4600–4605[CrossRef]
BluyssenH. A.,
MuzaffarR.,
VlieststraR. J.,
van der MadeA. C.,
LeungS.,
StarkG. R.,
KerrI. M.,
TrapmanJ.,
LevyD. E.1995; Combinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses. Proc Natl Acad Sci U S A 92:5645–5649[CrossRef]
BonvinM.,
AchermannF.,
GreeveI.,
StrokaD.,
KeoghA.,
InderbitzinD.,
CandinasD.,
SommerP.,
Wain-HobsonS.other authors2006; Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology 43:1364–1374[CrossRef]
BordenK. L.,
Campbell DwyerE. J.,
SalvatoM. S.1998a; An arenavirus RING (zinc-binding) protein binds the oncoprotein promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the cytoplasm. J Virol 72:758–766
BordenK. L.,
CampbelldwyerE. J.,
CarlileG. W.,
DjavaniM.,
SalvatoM. S.1998b; Two RING finger proteins, the oncoprotein PML and the arenavirus Z protein, colocalize with the nuclear fraction of the ribosomal P proteins. J Virol 72:3819–3826
BossertB.,
ConzelmannK. K.2002; Respiratory syncytial virus (RSV) nonstructural (NS) proteins as host range determinants: a chimeric bovine RSV with NS genes from human RSV is attenuated in interferon-competent bovine cells. J Virol 76:4287–4293[CrossRef]
BouloyM.,
JanzenC.,
VialatP.,
KhunH.,
PavlovicJ.,
HuerreM.,
HallerO.2001; Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus nonstructural protein NSs. J Virol 75:1371–1377[CrossRef]
BrzozkaK.,
FinkeS.,
ConzelmannK. K.2005; Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. J Virol 79:7673–7681[CrossRef]
Camus-BouclainvilleC.,
FietteL.,
BouchihaS.,
PignoletB.,
CounorD.,
FilipeC.,
GelfiJ.,
Messud-PetitF.2004; A virulence factor of myxoma virus colocalizes with NF- κ B in the nucleus and interferes with inflammation. J Virol 78:2510–2516[CrossRef]
CapobianchiM. R.,
AnkelH.,
AmeglioF.,
PaganelliR.,
PizzoliP. M.,
DianzaniF.1992; Recombinant glycoprotein 120 of human immunodeficiency virus is a potent interferon inducer. AIDS Res Hum Retroviruses 8:575–579[CrossRef]
CarlosT. S.,
FearnsR.,
RandallR. E.2005; Interferon-induced alterations in the pattern of parainfluenza virus 5 transcription and protein synthesis and the induction of virus inclusion bodies. J Virol 79:14112–14121[CrossRef]
CassadyK. A.2005; Human cytomegalovirus TRS1 and IRS1 gene products block the double-stranded-RNA-activated host protein shutoff response induced by herpes simplex virus type 1 infection. J Virol 79:8707–8715[CrossRef]
CastelliJ. C.,
HasselB. A.,
MaranA.,
ParanjapeJ.,
HewittJ. A.,
LiX. L.,
HsuY. T.,
SilvermanR. H.,
YouleR. J.1998; The role of 2′-5′ oligoadenylate-activated ribonuclease L in apoptosis. Cell Death Differ 5:313–320[CrossRef]
ChangH. W.,
WatsonJ. C.,
JacobsB. L.1992; The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci U S A 89:4825–4829[CrossRef]
ChariotA.,
LeonardiA.,
MullerJ.,
BonifM.,
BrownK.,
SiebenlistU.2002; Association of the adaptor TANK with the I κ B kinase (IKK) regulator NEMO connects IKK complexes with IKKϵ and TBK1 kinases. J Biol Chem 277:37029–37036[CrossRef]
Chatterjee-KishoreM.,
van Den AkkerF.,
StarkG. R.2000a; Adenovirus E1A down-regulates LMP2 transcription by interfering with the binding of Stat1 to IRF1. J Biol Chem 275:20406–20411[CrossRef]
Chatterjee-KishoreM.,
WrightK. L.,
TingJ. P.,
StarkG. R.2000b; How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene. EMBO J 19:4111–4122[CrossRef]
ChatziandreouN.,
YoungD.,
AndrejevaJ.,
GoodbournS.,
RandallR. E.2002; Differences in interferon sensitivity and biological properties of two related isolates of simian virus 5: a model for virus persistence. Virology 293:234–242[CrossRef]
ChenZ.,
LiY.,
KrugR. M.1999; Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3′-end processing machinery. EMBO J 18:2273–2283[CrossRef]
ChengG.,
ZhongJ.,
ChisariF. V.2006; Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms. Proc Natl Acad Sci U S A 103:8499–8504[CrossRef]
ChengG.,
ZhongJ.,
ChungJ.,
ChisariF. V.2007; Double-stranded DNA and double-stranded RNA induce a common antiviral signaling pathway in human cells. Proc Natl Acad Sci U S A 104:9035–9040[CrossRef]
ChildS. J.,
HansonL. K.,
BrownC. E.,
JanzenD. M.,
GeballeA. P.2006; Double-stranded RNA binding by a heterodimeric complex of murine cytomegalovirus m142 and m143 proteins. J Virol 80:10173–10180[CrossRef]
ChildsK.,
StockN.,
RossC.,
AndrejevaJ.,
HiltonL.,
SkinnerM.,
RandallR.,
GoodbournS.2007; mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology 359:190–200[CrossRef]
ChinK. C.,
CresswellP.2001; Viperin (cig5), an IFN-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci U S A 98:15125–15130[CrossRef]
ChinY. E.,
KitagawaM.,
KuidaK.,
FlavellR. A.,
FuX. Y.1997; Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 17:5328–5337
ChinsangaramJ.,
PicconeM. E.,
GrubmanM. J.1999; Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J Virol 73:9891–9898
CiccaglioneA. R.,
StellacciE.,
MarcantonioC.,
MutoV.,
EquestreM.,
MarsiliG.,
RapicettaM.,
BattistiniA.2007; Repression of interferon regulatory factor 1 by hepatitis C virus core protein results in inhibition of antiviral and immunomodulatory genes. J Virol 81:202–214[CrossRef]
ClarkM. E.,
LiebermanP. M.,
BerkA. J.,
DasguptaA.1993; Direct cleavage of human TATA-binding protein by poliovirus protease 3C in vivo and in vitro. Mol Cell Biol 13:1232–1237
ColamoniciO. R.,
DomanskiP.,
SweitzerS. M.,
LarnerA.,
BullerR. M. L.1995; Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon α transmembrane signaling. J Biol Chem 270:15974–15978[CrossRef]
ConnorJ. H.,
LylesD. S.2005; Inhibition of host and viral translation during vesicular stomatitis virus infection. eIF2 is responsible for the inhibition of viral but not host translation. J Biol Chem 280:13512–13519[CrossRef]
CoorayS.,
BaharM. W.,
AbresciaN. G.,
McVeyC. E.,
BartlettN. W.,
ChenR. A.,
StuartD. I.,
GrimesJ. M.,
SmithG. L.2007; Functional and structural studies of the vaccinia virus virulence factor N1 reveal a Bcl-2-like anti-apoptotic protein. J Gen Virol 88:1656–1666[CrossRef]
CrozeE.,
UsachevaA.,
AsarnowD.,
MinshallR. D.,
PerezH. D.,
ColamoniciO.2000; Receptor for activated C-kinase (RACK-1), a WD motif-containing protein, specifically associates with the human type I IFN receptor. J Immunol 165:5127–5132[CrossRef]
CuddihyA. R.,
WongA. H.,
TamN. W.,
LiS.,
KoromilasA. E.1999a; The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene 18:2690–2702[CrossRef]
Cusson-HermanceN.,
KhuranaS.,
LeeT. H.,
FitzgeraldK. A.,
KelliherM. A.2005; Rip1 mediates the Trif-dependent Toll-like receptor 3- and 4-induced NF- κ B activation but does not contribute to interferon regulatory factor 3 activation. J Biol Chem 280:36560–36566[CrossRef]
DaiC.,
KrantzS. B.1999; Interferon γ induces upregulation and activation of caspases 1, 3, and 8 to produce apoptosis in human erythroid progenitor cells. Blood 93:3309–3316
DasS.,
DasguptaA.1993; Identification of the cleavage site and determinants required for poliovirus 3CPro-catalyzed cleavage of human TATA-binding transcription factor TBP. J Virol 67:3326–3331
de BouteillerO.,
MerckE.,
HasanU. A.,
HubacS.,
BenguiguiB.,
TrinchieriG.,
BatesE. E.,
CauxC.2005; Recognition of double-stranded RNA by human Toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J Biol Chem 280:38133–38145[CrossRef]
de Los SantosT.,
de Avila BottonS.,
WeiblenR.,
GrubmanM. J.2006; The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J Virol 80:1906–1914[CrossRef]
de LucasS.,
BartolomeJ.,
CarrenoV.2005; Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes. J Infect Dis 191:93–99[CrossRef]
DebD. K.,
SassanoA.,
LekmineF.,
MajchrzakB.,
VermaA.,
KambhampatiS.,
UddinS.,
RahmanA.,
FishE. N.,
PlataniasL. C.2003; Activation of protein kinase C δ by IFN-gamma. J Immunol 171:267–273[CrossRef]
DeckerT.,
LewD. J.,
DarnellJ. E. J.1991; Two distinct alpha-interferon-dependent signal transduction pathways may contribute to activation of transcription of the guanylate-binding protein gene. Mol Cell Biol 11:5147–5153
DelhayeS.,
van PeschV.,
MichielsT.2004; The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins. J Virol 78:4357–4362[CrossRef]
DengL.,
WangC.,
SpencerE.,
YangL.,
BraunA.,
YouJ.,
SlaughterC.,
PickartC.,
ChenZ. J.2000; Activation of the I κ B kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103:351–361[CrossRef]
DesmyterJ.,
MelnickJ. L.,
RawlsW. E.1968; Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero. J Virol 2:955–961
DevaneyM. A.,
VakhariaV. N.,
LloydR. E.,
EhrenfeldE.,
GrubmanM. J.1988; Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol 62:4407–4409
DiaoF.,
LiS.,
TianY.,
ZhangM.,
XuL. G.,
ZhangY.,
WangR. P.,
ChenD.,
ZhaiZ.other authors2007; Negative regulation of MDA5- but not RIG-I-mediated innate antiviral signaling by the dihydroxyacetone kinase. Proc Natl Acad Sci U S A 104:11706–11711[CrossRef]
DidcockL.,
YoungD. F.,
GoodbournS.,
RandallR. E.1999a; The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation. J Virol 73:9928–9933
DieboldS. S.,
KaishoT.,
HemmiH.,
AkiraS.,
Reis. e SousaC.
2004; Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:1529–1531[CrossRef]
DieboldS. S.,
MassacrierC.,
AkiraS.,
PaturelC.,
MorelY.,
Reis. e SousaC.
2006; Nucleic acid agonists for Toll-like receptor 7 are defined by the presence of uridine ribonucleotides. Eur J Immunol 36:3256–3267[CrossRef]
DillonP. J.,
ParksG. D.2007; Role for the phosphoprotein P subunit of the paramyxovirus polymerase in limiting induction of host cell antiviral responses. J Virol 81:11116–11127[CrossRef]
DiPernaG.,
StackJ.,
BowieA. G.,
BoydA.,
KotwalG.,
ZhangZ.,
ArvikarS.,
LatzE.,
FitzgeraldK. A.,
MarshallW. L.2004; Poxvirus protein N1L targets the I- κ B kinase complex, inhibits signaling to NF- κ B by the tumor necrosis factor superfamily of receptors, and inhibits NF- κ B and IRF3 signaling by Toll-like receptors. J Biol Chem 279:36570–36578[CrossRef]
DjavaniM.,
RodasJ.,
LukashevichI. S.,
HorejshD.,
PandolfiP. P.,
BordenK. L.,
SalvatoM. S.2001; Role of the promyelocytic leukemia protein PML in the interferon sensitivity of lymphocytic choriomeningitis virus. J Virol 75:6204–6208[CrossRef]
DoucasV.,
IshovA. M.,
RomoA.,
JuguilonH.,
WeitzmanM. D.,
EvansR. M.,
MaulG. G.1996; Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev 10:196–207[CrossRef]
DraganA. I.,
HargreavesV. V.,
MakeyevaE. N.,
PrivalovP. L.2007; Mechanisms of activation of interferon regulator factor 3: the role of C-terminal domain phosphorylation in IRF-3 dimerization and DNA binding. Nucleic Acids Res 35:3525–3534[CrossRef]
DuongF. H.,
FilipowiczM.,
TripodiM.,
La MonicaN.,
HeimM. H.2004; Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A. Gastroenterology 126:263–277[CrossRef]
EaC. K.,
DengL.,
XiaZ. P.,
PinedaG.,
ChenZ. J.2006; Activation of IKK by TNF α requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 22:245–257[CrossRef]
EdelmannK. H.,
Richardson-BurnsS.,
AlexopoulouL.,
TylerK. L.,
FlavellR. A.,
OldstoneM. B.2004; Does Toll-like receptor 3 play a biological role in virus infections?. Virology 322:231–238[CrossRef]
EppersonD. E.,
ArnoldD.,
SpiesT.,
CresswellP.,
PoberJ. S.,
JohnsonD. R.1992; Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells. J Immunol 149:3297–3301
EspertL.,
CodognoP.,
Biard-PiechaczykM.2007; Involvement of autophagy in viral infections: antiviral function and subversion by viruses. J Mol Med 85:811–823[CrossRef]
EtchisonD.,
MilburnS. C.,
EderyI.,
SonenbergN.,
HersheyJ. W.1982; Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220,000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J Biol Chem 257:14806–14810
EverlyD. N.Jr,
FengP.,
MianI. S.,
ReadG. S.2002; mRNA degradation by the virion host shutoff (Vhs) protein of herpes simplex virus: genetic and biochemical evidence that Vhs is a nuclease. J Virol 76:8560–8571[CrossRef]
FengZ.,
CervenyM.,
YanZ.,
HeB.2007; The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. J Virol 81:182–192[CrossRef]
FernandezM.,
QuirogaJ. A.,
CarrenoV.2003; Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins. J Gen Virol 84:2073–2082[CrossRef]
FerranM. C.,
Lucas-LenardJ. M.1997; The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter. J Virol 71:371–377
FerrantiniM.,
CaponeI.,
BelardelliF.2007; Interferon- α and cancer: mechanisms of action and new perspectives of clinical use. Biochimie 89:884–893[CrossRef]
FitzgeraldK. A.,
Palsson-McDermottE. M.,
BowieA. G.,
JefferiesC. A.,
MansellA. S.,
BradyG.,
BrintE.,
DunneA.,
GrayP.other authors2001; Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413:78–83[CrossRef]
FitzgeraldK. A.,
McWhirterS. M.,
FaiaK. L.,
RoweD. C.,
LatzE.,
GolenbockD. T.,
CoyleA. J.,
LiaoS. M.,
ManiatisT.2003; IKKϵ and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491–496
FriedmanJ. M.,
HorwitzM. S.2002; Inhibition of tumor necrosis factor alpha-induced NF- κ B activation by the adenovirus E3–10.4/14.5K complex. J Virol 76:5515–5521[CrossRef]
FriedrichsW. E.,
ReddyS. V.,
BruderJ. M.,
CundyT.,
CornishJ.,
SingerF. R.,
RoodmanG. D.2002; Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease. J Bone Miner Res 17:145–151[CrossRef]
FrolovaE. I.,
FayzulinR. Z.,
CookS. H.,
GriffinD. E.,
RiceC. M.,
FrolovI.2002; Roles of nonstructural protein nsP2 and alpha/beta interferons in determining the outcome of Sindbis virus infection. J Virol 76:11254–11264[CrossRef]
GarciaM. A.,
GilJ.,
VentosoI.,
GuerraS.,
DomingoE.,
RivasC.,
EstebanM.2006; Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol Mol Biol Rev 70:1032–1060[CrossRef]
Garcia-SastreA.2007; De-ISGylating and de-ubiquitinating activities of viral OUT-like proteins. In Gordon Research Conference 2007: Viruses and Cells 3–8 June 2007 oral presentation Tilton School; Tilton, NH, USA:
GarcinD.,
LatorreP.,
KolakofskyD.1999; Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state. J Virol 73:6559–6565
GarcinD.,
CurranJ.,
KolakofskyD.2000; Sendai virus C proteins must interact directly with cellular components to interfere with interferon action. J Virol 74:8823–8830[CrossRef]
GarcinD.,
CurranJ.,
ItohM.,
KolakofskyD.2001; Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response. J Virol 75:6800–6807[CrossRef]
GarcinD.,
MarqJ. B.,
StrahleL.,
le MercierP.,
KolakofskyD.2002; All four Sendai virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation. Virology 295:256–265[CrossRef]
GarcinD.,
MarqJ. B.,
GoodbournS.,
KolakofskyD.2003; The amino-terminal extensions of the longer Sendai virus C proteins modulate pY701-Stat1 and bulk Stat1 levels independently of interferon signaling. J Virol 77:2321–2329[CrossRef]
GiannakopoulosN. V.,
LuoJ. K.,
PapovV.,
ZouW.,
LenschowD. J.,
JacobsB. S.,
BordenE. C.,
LiJ.,
VirginH. W.,
ZhangD. E.2005; Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochem Biophys Res Commun 336:496–506[CrossRef]
GilJ.,
AlcamiJ.,
EstebanM.1999; Induction of apoptosis by double-stranded-RNA-dependent protein kinase (PKR) involves the α subunit of eukaryotic translation initiation factor 2 and NF- κ B. Mol Cell Biol 19:4653–4663
GitlinL.,
BarchetW.,
GilfillanS.,
CellaM.,
BeutlerB.,
FlavellR. A.,
DiamondM. S.,
ColonnaM.2006; Essential role of mda-5 in type I IFN responses to polyriboinosinic : polyribocytidylic acid and encephalomyocarditis picornavirus. Proc Natl Acad Sci U S A 103:8459–8464[CrossRef]
GordonM. T.,
AndersonD. C.,
SharpeP. T.1991; Canine distemper virus localised in bone cells of patients with Paget's disease. Bone 12:195–201[CrossRef]
GotohB.,
TakeuchiK.,
KomatsuT.,
YokooJ.2003a; The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. J Virol 77:3360–3370[CrossRef]
GotohB.,
KomatsuT.,
TakeuchiK.,
YokooJ.2003b; The C-terminal half-fragment of the Sendai virus C protein prevents the gamma-activated factor from binding to a gamma-activated sequence site. Virology 316:29–40[CrossRef]
GradiA.,
SvitkinY. V.,
ImatakaH.,
SonenbergN.1998; Proteolysis of human eukaryotic translation initiation factor eIF4GII, but not eIF4GI, coincides with the shutoff of host protein synthesis after poliovirus infection. Proc Natl Acad Sci U S A 95:11089–11094[CrossRef]
GraffJ. W.,
EwenJ.,
EttayebiK.,
HardyM. E.2007; Zinc-binding domain of rotavirus NSP1 is required for proteasome-dependent degradation of IRF3 and autoregulatory NSP1 stability. J Gen Virol 88:613–620[CrossRef]
GrahamR. R.,
KyogokuC.,
SigurdssonS.,
VlasovaI. A.,
DaviesL. R.,
BaechlerE. C.,
PlengeR. M.,
KoeuthT.,
OrtmannW. A.other authors2007; Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 104:6758–6763[CrossRef]
GuoZ.,
ChenL. M.,
ZengH.,
GomezJ. A.,
PlowdenJ.,
FujitaT.,
KatzJ. M.,
DonisR. O.,
SambharaS.2006; NS1 protein of influenza A virus inhibits the function of intracytoplasmic pathogen sensor, RIG-I. Am J Respir Cell Mol Biol 36:263–269
GustinK. E.,
SarnowP.2001; Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition. EMBO J 20:240–249[CrossRef]
HagmaierK.,
GelderblomH. R.,
KochsG.2004; Functional comparison of the two gene products of Thogoto virus segment 6. J Gen Virol 85:3699–3708[CrossRef]
HagmaierK.,
StockN.,
PreciousB.,
ChildsK.,
WangL. F.,
GoodbournS.,
RandallR. E.2007; Mapuera virus, a rubulavirus that inhibits interferon signalling in a wide variety of mammalian cells without degrading STATs. J Gen Virol 88:956–966[CrossRef]
HaleB. G.,
JacksonD.,
ChenY. H.,
LambR. A.,
RandallR. E.2006; Influenza A virus NS1 protein binds p85 β and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A 103:14194–14199[CrossRef]
HartwigD.,
SchutteC.,
WarneckeJ.,
DornI.,
HennigH.,
KirchnerH.,
SchlenkeP.2006; The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon- α -stimulated host cells. J Viral Hepat 13:150–157[CrossRef]
HatziioannouT.,
Perez-CaballeroD.,
YangA.,
CowanS.,
BieniaszP. D.2004; Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5 α . Proc Natl Acad Sci U S A 101:10774–10779[CrossRef]
HaymanA.,
ComelyS.,
LackenbyA.,
MurphyS.,
McCauleyJ.,
GoodbournS.,
BarclayW.2006; Variation in the ability of human influenza A viruses to induce and inhibit the IFN- β pathway. Virology 347:52–64[CrossRef]
HaymanA.,
ComelyS.,
LackenbyA.,
HartgrovesL. C.,
GoodbournS.,
McCauleyJ. W.,
BarclayW. S.2007; NS1 proteins of avian influenza A viruses can act as antagonists of the human alpha/beta interferon response. J Virol 81:2318–2327[CrossRef]
HaynesL. M.,
MooreD. D.,
Kurt-JonesE. A.,
FinbergR. W.,
AndersonL. J.,
TrippR. A.2001; Involvement of Toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol 75:10730–10737[CrossRef]
HeB.,
LinG. Y.,
DurbinJ. E.,
DurbinR. K.,
LambR. A.2001; The SH integral membrane protein of the paramyxovirus simian virus 5 is required to block apoptosis in MDBK cells. J Virol 75:4068–4079[CrossRef]
HeB.,
PatersonR. G.,
StockN.,
DurbinJ. E.,
DurbinR. K.,
GoodbournS.,
RandallR. E.,
LambR. A.2002; Recovery of paramyxovirus simian virus 5 with a V protein lacking the conserved cysteine-rich domain: the multifunctional V protein blocks both interferon- β induction and interferon signaling. Virology 303:15–32[CrossRef]
HeimM. H.,
MoradpourD.,
BlumH. E.1999; Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway. J Virol 73:8469–8475
HelbigK. J.,
LauD. T.,
SemendricL.,
HarleyH. A.,
BeardM. R.2005; Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector. Hepatology 42:702–710[CrossRef]
HerL. S.,
LundE.,
DahlbergJ. E.1997; Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus. Science 276:1845–1848[CrossRef]
HerzerK.,
WeyerS.,
KrammerP. H.,
GalleP. R.,
HofmannT. G.2005; Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells. Cancer Res 65:10830–10837[CrossRef]
HiltonL.,
MoganeradjK.,
ZhangG.,
ChenY. H.,
RandallR. E.,
McCauleyJ. W.,
GoodbournS.2006; The NPro product of bovine viral diarrhea virus inhibits DNA binding by interferon regulatory factor-3 and targets it for proteasomal degradation. J Virol 80:11723–11732[CrossRef]
HiscottJ.,
NguyenT. L.,
ArguelloM.,
NakhaeiP.,
PazS.2006b; Manipulation of the nuclear factor- κ B pathway and the innate immune response by viruses. Oncogene 25:6844–6867[CrossRef]
HoebeK.,
DuX.,
GeorgelP.,
JanssenE.,
TabetaK.,
KimS. O.,
GoodeJ.,
LinP.,
MannN.other authors2003; Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743–748[CrossRef]
HondaK.,
YanaiH.,
MizutaniT.,
NegishiH.,
ShimadaN.,
SuzukiN.,
OhbaY.,
TakaokaA.,
YehW. C.,
TaniguchiT.2004; Role of a transductional-transcriptional processor complex involving MyD88 and IRF-7 in Toll-like receptor signaling. Proc Natl Acad Sci U S A 101:15416–15421[CrossRef]
HoppeA.,
BeechS. J.,
DimmockJ.,
LeppardK. N.2006; Interaction of the adenovirus type 5 E4 Orf3 protein with promyelocytic leukemia protein isoform II is required for ND10 disruption. J Virol 80:3042–3049[CrossRef]
HoshinoK.,
SugiyamaT.,
MatsumotoM.,
TanakaT.,
SaitoM.,
HemmiH.,
OharaO.,
AkiraS.,
KaishoT.2006; I κ B kinase- α is critical for interferon- α production induced by Toll-like receptors 7 and 9. Nature 440:949–953[CrossRef]
HoylandJ. A.,
DixonJ. A.,
BerryJ. L.,
DaviesM.,
SelbyP. L.,
MeeA. P.2003; A comparison of in situ hybridisation, reverse transcriptase-polymerase chain reaction (RT-PCR) and in situ-RT-PCR for the detection of canine distemper virus RNA in Paget's disease. J Virol Methods 109:253–259[CrossRef]
HuangZ.,
KrishnamurthyS.,
PandaA.,
SamalS. K.2003; Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist. J Virol 77:8676–8685[CrossRef]
HuangJ.,
SmirnovS. V.,
Lewis-AntesA.,
BalanM.,
LiW.,
TangS.,
SilkeG. V.,
PutzM. M.,
SmithG. L.,
KotenkoS. V.2007; Inhibition of type I and type III interferons by a secreted glycoprotein from Yaba-like disease virus. Proc Natl Acad Sci U S A 104:9822–9827[CrossRef]
HuiD. J.,
BhaskerC. R.,
MerrickW. C.,
SenG. C.2003; Viral stress-inducible protein p56 inhibits translation by blocking the interaction of eIF3 with the ternary complex eIF2.GTP.Met-tRNAi. J Biol Chem 278:39477–39482[CrossRef]
HuyeL. E.,
NingS.,
KelliherM.,
PaganoJ. S.2007; Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination. Mol Cell Biol 27:2910–2918[CrossRef]
ImaniF.,
JacobsB. L.1988; Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein. Proc Natl Acad Sci U S A 85:7887–7891[CrossRef]
IqbalM.,
PooleE.,
GoodbournS.,
McCauleyJ. W.2004; Role for bovine viral diarrhea virus Erns glycoprotein in the control of activation of beta interferon by double-stranded RNA. J Virol 78:136–145[CrossRef]
ItoT.,
YangM.,
MayW. S.1999; RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling. J Biol Chem 274:15427–15432[CrossRef]
JaworskaJ.,
GravelA.,
FinkK.,
GrandvauxN.,
FlamandL.2007; Inhibition of transcription of the beta interferon gene by the human herpesvirus 6 immediate-early 1 protein. J Virol 81:5737–5748[CrossRef]
JiangZ.,
MakT. W.,
SenG.,
LiX.2004; Toll-like receptor 3-mediated activation of NF- κ B and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN- β . Proc Natl Acad Sci U S A 101:3533–3538[CrossRef]
JoachimsM.,
Van BreugelP. C.,
LloydR. E.1999; Cleavage of poly(A)-binding protein by enterovirus proteases concurrent with inhibition of translation in vitro. J Virol 73:718–727
JohnstonM. D.1981; The characteristics required for a Sendai virus preparation to induce high levels of interferon in human lymphoblastoid cells. J Gen Virol 56:175–184[CrossRef]
JohnstonJ. B.,
NazarianS. H.,
NataleR.,
McFaddenG.2005; Myxoma virus infection of primary human fibroblasts varies with cellular age and is regulated by host interferon responses. Virology 332:235–248[CrossRef]
JooM.,
HahnY. S.,
KwonM.,
SadikotR. T.,
BlackwellT. S.,
ChristmanJ. W.2005; Hepatitis C virus core protein suppresses NF- κ B activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta. J Virol 79:7648–7657[CrossRef]
JostS.,
TurelliP.,
MangeatB.,
ProtzerU.,
TronoD.2007; Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons. J Virol 81:10588–10596[CrossRef]
JurkM.,
HeilF.,
VollmerJ.,
SchetterC.,
KriegA. M.,
WagnerH.,
LipfordG.,
BauerS.2002; Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat Immunol 3:499[CrossRef]
KanayamaA.,
SethR. B.,
SunL.,
EaC. K.,
HongM.,
ShaitoA.,
ChiuY. H.,
DengL.,
ChenZ. J.2004; TAB2 and TAB3 activate the NF- κ B pathway through binding to polyubiquitin chains. Mol Cell 15:535–548[CrossRef]
KangH.,
KimE. T.,
LeeH. R.,
ParkJ. J.,
GoY. Y.,
ChoiC. Y.,
AhnJ. H.2006; Inhibition of SUMO-independent PML oligomerization by the human cytomegalovirus IE1 protein. J Gen Virol 87:2181–2190[CrossRef]
KarikoK.,
BucksteinM.,
NiH.,
WeissmanD.2005; Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23:165–175[CrossRef]
KatoA.,
OhnishiY.,
KohaseM.,
SaitoS.,
TashiroM.,
NagaiY.2001; Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. J Virol 75:3802–3810[CrossRef]
KatoH.,
TakeuchiO.,
SatoS.,
YoneyamaM.,
YamamotoM.,
MatsuiK.,
UematsuS.,
JungA.,
KawaiT.other authors2006; Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101–105[CrossRef]
KatsoulidisE.,
LiY.,
MearsH.,
PlataniasL. C.2005; The p38 mitogen-activated protein kinase pathway in interferon signal transduction. J Interferon Cytokine Res 25:749–756[CrossRef]
KawaiT.,
SatoS.,
IshiiK. J.,
CobanC.,
HemmiH.,
YamamotoM.,
TeraiK.,
MatsudaM.,
InoueJ.other authors2004; Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5:1061–1068[CrossRef]
KawakamiT.,
MatsumotoM.,
SatoM.,
HaradaH.,
TaniguchiT.,
KitagawaM.1995; Possible involvement of the transcription factor ISGF3 γ in virus-induced expression of the IFN- β gene. FEBS Lett 358:225–229[CrossRef]
KeckesovaZ.,
YlinenL. M.,
TowersG. J.2004; The human and African green monkey TRIM5 α genes encode Ref1 and Lv1 retroviral restriction factor activities. Proc Natl Acad Sci U S A 101:10780–10785[CrossRef]
KerscherO.,
FelberbaumR.,
HochstrasserM.2006; Modification of proteins by ubiquitin and ubiquitin-like proteins. Annu Rev Cell Dev Biol 22:159–180[CrossRef]
KimM. J.,
LathamA. G.,
KrugR. M.2002; Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique. Proc Natl Acad Sci U S A 99:10096–10101[CrossRef]
KirchwegerR.,
ZieglerE.,
LamphearB. J.,
WatersD.,
LiebigH. D.,
SommergruberW.,
SobrinoF.,
HohenadlC.,
BlaasD.other authors1994; Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 γ . J Virol 68:5677–5684
KolumamG. A.,
ThomasS.,
ThompsonL. J.,
SprentJ.,
Murali-KrishnaK.2005; Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202:637–650[CrossRef]
KomatsuT.,
TakeuchiK.,
YokooJ.,
GotohB.2002; Sendai virus C protein impairs both phosphorylation and dephosphorylation processes of Stat1. FEBS Lett 511:139–144[CrossRef]
Kopecky-BrombergS. A.,
Martinez-SobridoL.,
FriemanM.,
BaricR. A.,
PaleseP.2007; Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol 81:548–557[CrossRef]
KozukaY.,
YamashitaY.,
KawanoM.,
TsurudomeM.,
ItoM.,
NishioM.,
KomadaH.,
ItoY.2003; Identification of amino acids essential for the human parainfluenza type 2 virus V protein to lower the intracellular levels of the STAT2. Virology 317:208–219[CrossRef]
KozyrevS. V.,
LewenS.,
ReddyP. M.,
Pons-EstelB.,
WitteT.,
JunkerP.,
LaustrupH.,
GutierrezC.,
SuarezA.other authors2007; Structural insertion/deletion variation in IRF5 is associated with a risk haplotype and defines the precise IRF5 isoforms expressed in systemic lupus erythematosus. Arthritis Rheum 56:1234–1241[CrossRef]
KrishnamurthyS.,
TakimotoT.,
ScroggsR. A.,
PortnerA.2006; Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines. J Virol 80:5145–5155[CrossRef]
KrugA.,
FrenchA. R.,
BarchetW.,
FischerJ. A.,
DzionekA.,
PingelJ. T.,
OrihuelaM. M.,
AkiraS.,
YokoyamaW. M.,
ColonnaM.2004; TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21:107–119[CrossRef]
KubotaT.,
YokosawaN.,
YokotaS.,
FujiiN.2001; C terminal Cys-rich region of mumps virus structural V protein correlates with block of interferon α and γ signal transduction pathway through decrease of STAT 1- α . Biochem Biophys Res Commun 283:255–259[CrossRef]
KubotaT.,
YokosawaN.,
YokotaS.,
FujiiN.2002; Association of mumps virus V protein with RACK1 results in dissociation of STAT-1 from the alpha interferon receptor complex. J Virol 76:12676–12682[CrossRef]
KubotaT.,
YokosawaN.,
YokotaS.,
FujiiN.,
TashiroM.,
KatoA.2005; Mumps virus V protein antagonizes interferon without the complete degradation of STAT1. J Virol 79:4451–4459[CrossRef]
KumarP. P.,
BischofO.,
PurbeyP. K.,
NotaniD.,
UrlaubH.,
DejeanA.,
GalandeS.2007; Functional interaction between PML and SATB1 regulates chromatin-loop architecture and transcription of the MHC class I locus. Nat Cell Biol 9:45–56[CrossRef]
Kurt-JonesE. A.,
PopovaL.,
KwinnL.,
HaynesL. M.,
JonesL. P.,
TrippR. A.,
WalshE. E.,
FreemanM. W.,
GolenbockD. T.other authors2000; Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1:398–401[CrossRef]
La RoccaS. A.,
HerbertR. J.,
CrookeH.,
DrewT. W.,
WilemanT. E.,
PowellP. P.2005; Loss of interferon regulatory factor 3 in cells infected with classical swine fever virus involves the N-terminal protease, Npro. J Virol 79:7239–7247[CrossRef]
LanglandJ. O.,
PettifordS.,
JiangB.,
JacobsB. L.1994; Products of the porcine group C rotavirus NSP3 gene bind specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase PKR. J Virol 68:3821–3829
Le BonA.,
EtchartN.,
RossmannC.,
AshtonM.,
HouS.,
GewertD.,
BorrowP.,
ToughD. F.2003; Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon. Nat Immunol 4:1009–1015[CrossRef]
Le BonA.,
DurandV.,
KamphuisE.,
ThompsonC.,
Bulfone-PausS.,
RossmannC.,
KalinkeU.,
ToughD. F.2006; Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming. J Immunol 176:4682–4689[CrossRef]
Le MayN.,
DubaeleS.,
Proietti De SantisL.,
BillecocqA.,
BouloyM.,
EglyJ. M.2004; TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116:541–550[CrossRef]
LeibD. A.,
MachalekM. A.,
WilliamsB. R.,
SilvermanR. H.,
VirginH. W.2000; Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc Natl Acad Sci U S A 97:6097–6101[CrossRef]
LenschowD. J.,
GiannakopoulosN. V.,
GunnL. J.,
JohnstonC.,
O'GuinA. K.,
SchmidtR. E.,
LevineB.,
VirginH. W.IV2005; Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J Virol 79:13974–13983[CrossRef]
LiX.,
LeungS.,
QureshiS.,
DarnellJ. E.Jr,
StarkG. R.1996; Formation of STAT1–STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon- α . J Biol Chem 271:5790–5794[CrossRef]
LiW.,
Ross-SmithN.,
ProudC. G.,
BelshamG. J.2001a; Cleavage of translation initiation factor 4AI (eIF4AI) but not eIF4AII by foot-and-mouth disease virus 3C protease: identification of the eIF4AI cleavage site. FEBS Lett 507:1–5[CrossRef]
LiY.,
ChenZ. Y.,
WangW.,
BakerC. C.,
KrugR. M.2001b; The 3′-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo. RNA 7:920–931[CrossRef]
LiK.,
FoyE.,
FerreonJ. C.,
NakamuraM.,
FerreonA. C.,
IkedaM.,
RayS. C.,
GaleM.Jr,
LemonS. M.2005a; Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 102:2992–2997[CrossRef]
LiX. D.,
SunL.,
SethR. B.,
PinedaG.,
ChenZ. J.2005c; Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 102:17717–17722[CrossRef]
LiS.,
MinJ. Y.,
KrugR. M.,
SenG. C.2006b; Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 349:13–21[CrossRef]
LinR.,
GeninP.,
MamaneY.,
HiscottJ.2000; Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol Cell Biol 20:6342–6353[CrossRef]
LinR.,
NoyceR. S.,
CollinsS. E.,
EverettR. D.,
MossmanK. L.2004a; The herpes simplex virus ICP0 RING finger domain inhibits IRF3- and IRF7-mediated activation of interferon-stimulated genes. J Virol 78:1675–1684[CrossRef]
LinR. J.,
ChangB. L.,
YuH. P.,
LiaoC. L.,
LinY. L.2006b; Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism. J Virol 80:5908–5918[CrossRef]
LiptakovaH.,
KontsekovaE.,
AlcamiA.,
SmithG. L.,
KontsekP.1997; Analysis of an interaction between the soluble vaccinia virus-coded type I interferon (IFN)-receptor and human IFN- α 1 and IFN- α 2. Virology 232:86–90[CrossRef]
LiuW. J.,
ChenH. B.,
WangX. J.,
HuangH.,
KhromykhA. A.2004; Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. J Virol 78:12225–12235[CrossRef]
LiuW. J.,
WangX. J.,
MokhonovV. V.,
ShiP. Y.,
RandallR.,
KhromykhA. A.2005; Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J Virol 79:1934–1942[CrossRef]
LiuW. J.,
WangX. J.,
ClarkD. C.,
LobigsM.,
HallR. A.,
KhromykhA. A.2006; A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J Virol 80:2396–2404[CrossRef]
LooY. M.,
OwenD. M.,
LiK.,
EricksonA. K.,
JohnsonC. L.,
FishP. M.,
CarneyD. S.,
WangT.,
IshidaH.other authors2006; Viral and therapeutic control of IFN- β promoter stimulator 1 during hepatitis C virus infection. Proc Natl Acad Sci U S A 103:6001–6006[CrossRef]
LookD. C.,
RoswitW. T.,
FrickA. G.,
Gris-AlevyY.,
DickhausD. M.,
WalterM. J.,
HoltzmanM. J.1998; Direct suppression of Stat1 function during adenoviral infection. Immunity 9:871–880[CrossRef]
LuY.,
WambachM.,
KatzeM. G.,
KrugR. M.1995; Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 214:222–228[CrossRef]
LundJ. M.,
AlexopoulouL.,
SatoA.,
KarowM.,
AdamsN. C.,
GaleN. W.,
IwasakiA.,
FlavellR. A.2004; Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A 101:5598–5603[CrossRef]
MaitraR. K.,
McMillanN. A.,
DesaiS.,
McSwiggenJ.,
HovanessianA. G.,
SenG.,
WilliamsB. R.,
SilvermanR. H.1994; HIV-1 TAR RNA has an intrinsic ability to activate interferon-inducible enzymes. Virology 204:823–827[CrossRef]
MajumderS.,
ZhouL. Z.,
ChaturvediP.,
BabcockG.,
ArasS.,
RansohoffR. M.1998; p48/STAT-1 α -containing complexes play a predominant role in induction of IFN- γ -inducible protein, 10 kDa (IP-10) by IFN- γ alone or in synergy with TNF- α . J Immunol 161:4736–4744
MalakhovaO. A.,
YanM.,
MalakhovM. P.,
YuanY.,
RitchieK. J.,
KimK. I.,
PetersonL. F.,
ShuaiK.,
ZhangD. E.2003; Protein ISGylation modulates the JAK-STAT signaling pathway. Genes Dev 17:455–460[CrossRef]
MarqJ. B.,
BriniA.,
KolakofskyD.,
GarcinD.2007; Targeting of the Sendai virus C protein to the plasma membrane via a peptide-only membrane anchor. J Virol 81:3187–3197[CrossRef]
MartinandC.,
SalehzadaT.,
SilholM.,
LebleuB.,
BisbalC.1998; RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells. Eur J Biochem 254:248–255[CrossRef]
MartinandC.,
MontavonC.,
SalehzadaT.,
SilholM.,
LebleuB.,
BisbalC.1999; RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells. J Virol 73:290–296
Martinez-CostasJ.,
Gonzalez-LopezC.,
VakhariaV. N.,
BenaventeJ.2000; Possible involvement of the double-stranded RNA-binding core protein sigmaA in the resistance of avian reovirus to interferon. J Virol 74:1124–1131[CrossRef]
MatsumotoM.,
KikkawaS.,
KohaseM.,
MiyakeK.,
SeyaT.2002; Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 293:1364–1369[CrossRef]
MatsuyamaT.,
KimuraT.,
KitagawaM.,
PfefferK.,
KawakamiT.,
WatanabeN.,
KundigT.,
AmakawaR.,
KishiharaK.other authors1993; Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 75:83–97[CrossRef]
MeagerA.,
VisvalingamK.,
DilgerP.,
BryanD.,
WadhwaM.2005; Biological activity of interleukins-28 and -29: comparison with type I interferons. Cytokine 31:109–118[CrossRef]
MeeA. P.,
DixonJ. A.,
HoylandJ. A.,
DaviesM.,
SelbyP. L.,
MawerE. B.1998; Detection of canine distemper virus in 100 % of Paget's disease samples by in situ-reverse transcriptase-polymerase chain reaction. Bone 23:171–175[CrossRef]
MelchjorsenJ.,
JensenS. B.,
MalmgaardL.,
RasmussenS. B.,
WeberF.,
BowieA. G.,
MatikainenS.,
PaludanS. R.2005; Activation of innate defense against a paramyxovirus is mediated by RIG-I and TLR7 and TLR8 in a cell-type-specific manner. J Virol 79:12944–12951[CrossRef]
MelroeG. T.,
SilvaL.,
SchafferP. A.,
KnipeD. M.2007; Recruitment of activated IRF-3 and CBP/p300 to herpes simplex virus ICP0 nuclear foci: Potential role in blocking IFN- β induction. Virology 360:305–321[CrossRef]
MeylanE.,
CurranJ.,
HofmannK.,
MoradpourD.,
BinderM.,
BartenschlagerR.,
TschoppJ.2005; Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167–1172[CrossRef]
MibayashiM.,
Martinez-SobridoL.,
LooY. M.,
CardenasW. B.,
GaleM.Jr,
Garcia-SastreA.2007; Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. J Virol 81:514–524[CrossRef]
MillerD. M.,
RahillB. M.,
BossJ. M.,
LairmoreM. D.,
DurbinJ. E.,
WaldmanJ. W.,
SedmakD. D.1998; Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 187:675–683[CrossRef]
MillerD. M.,
ZhangY.,
RahillB. M.,
WaldmanW. J.,
SedmakD. D.1999; Human cytomegalovirus inhibits IFN- α -stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. J Immunol 162:6107–6113
MillsB. G.,
SingerF. R.,
WeinerL. P.,
SuffinS. C.,
StabileE.,
HolstP.1984; Evidence for both respiratory syncytial virus and measles virus antigens in the osteoclasts of patients with Paget's disease of bone. Clin Orthop Relat Res 183:303–311
MinJ. Y.,
KrugR. M.2006; The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2′-5′ oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A 103:7100–7105[CrossRef]
MinetaT.,
RabkinS. D.,
YazakiT.,
HunterW. D.,
MartuzaR. L.1995; Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nat Med 1:938–943[CrossRef]
MoscaJ. D.,
PithaP. M.1986; Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis. Mol Cell Biol 6:2279–2283
MossmanK.,
UptonC.,
BullerR. M.,
McFaddenG.1995b; Species specificity of ectromelia virus and vaccinia virus interferon- γ binding proteins. Virology 208:762–769[CrossRef]
Munoz-JordanJ. L.,
Sanchez-BurgosG. G.,
Laurent-RolleM.,
Garcia-SastreA.2003; Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A 100:14333–14338[CrossRef]
Munoz-JordanJ. L.,
Laurent-RolleM.,
AshourJ.,
Martinez-SobridoL.,
AshokM.,
LipkinW. I.,
Garcia-SastreA.2005; Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol 79:8004–8013[CrossRef]
MurphyJ. A.,
DuerstR. J.,
SmithT. J.,
MorrisonL. A.2003; Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J Virol 77:9337–9345[CrossRef]
NagaiY.,
KatoA.2004; Accessory genes of the Paramyxoviridae , a large family of nonsegmented negative-strand RNA viruses, as a focus of active investigation by reverse genetics. Curr Top Microbiol Immunol 283:197–248
NandaS. K.,
BaronM. D.2006; Rinderpest virus blocks type I and type II interferon action: role of structural and nonstructural proteins. J Virol 80:7555–7568[CrossRef]
NetterwaldJ. R.,
JonesT. R.,
BrittW. J.,
YangS. J.,
McCroneI. P.,
ZhuH.2004; Postattachment events associated with viral entry are necessary for induction of interferon-stimulated genes by human cytomegalovirus. J Virol 78:6688–6691[CrossRef]
NguyenK. B.,
Salazar-MatherT. P.,
DalodM. Y.,
Van DeusenJ. B.,
WeiX. Q.,
LiewF. Y.,
CaligiuriM. A.,
DurbinJ. E.,
BironC. A.2002; Coordinated and distinct roles for IFN- αβ , IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 169:4279–4287[CrossRef]
NishioM.,
TsurudomeM.,
ItoM.,
KawanoM.,
KomadaH.,
ItoY.2001; High resistance of human parainfluenza type 2 virus protein-expressing cells to the antiviral and anti-cell proliferative activities of alpha/beta interferons: cysteine-rich V-specific domain is required for high resistance to the interferons. J Virol 75:9165–9176[CrossRef]
NishioM.,
GarcinD.,
SimonetV.,
KolakofskyD.2002; The carboxyl segment of the mumps virus V protein associates with Stat proteins in vitro via a tryptophan-rich motif. Virology 300:92–99[CrossRef]
NoahD. L.,
TwuK. Y.,
KrugR. M.2003; Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3′ end processing of cellular pre-mRNAS. Virology 307:386–395[CrossRef]
NuovoM. A.,
NuovoG. J.,
MacConnellP.,
FordeA.,
SteinerG. C.1992; In situ analysis of Paget's disease of bone for measles-specific PCR-amplified cDNA. Diagn Mol Pathol 1:256–265
OganesyanG.,
SahaS. K.,
GuoB.,
HeJ. Q.,
ShahangianA.,
ZarnegarB.,
PerryA.,
ChengG.2006; Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439:208–211[CrossRef]
OhkaS.,
IgarashiH.,
NagataN.,
SakaiM.,
KoikeS.,
NochiT.,
KiyonoH.,
NomotoA.2007; Establishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptor. J Virol 81:7902–7912[CrossRef]
OhnoS.,
OnoN.,
TakedaM.,
TakeuchiK.,
YanagiY.2004; Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J Gen Virol 85:2991–2999[CrossRef]
OhnoS.,
OnoN.,
SekiF.,
TakedaM.,
KuraS.,
TsuzukiT.,
YanagiY.2007; Measles virus infection of SLAM (CD150) knockin mice reproduces tropism and immunosuppression in human infection. J Virol 81:1650–1659[CrossRef]
OkumuraF.,
ZouW.,
ZhangD. E.2007; ISG15 modification of the eIF4E cognate 4EHP enhances cap structure-binding activity of 4EHP. Genes Dev 21:255–260[CrossRef]
OllandA. M.,
Jane-ValbuenaJ.,
SchiffL. A.,
NibertM. L.,
HarrisonS. C.2001; Structure of the reovirus outer capsid and dsRNA-binding protein σ 3 at 1.8 Å resolution. EMBO J 20:979–989[CrossRef]
OnoguchiK.,
YoneyamaM.,
TakemuraA.,
AkiraS.,
TaniguchiT.,
NamikiH.,
FujitaT.2007; Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem 282:7576–7581
OoiC. G.,
WalshC. A.,
GallagherJ. A.,
FraserW. D.2000; Absence of measles virus and canine distemper virus transcripts in long-term bone marrow cultures from patients with Paget's disease of bone. Bone 27:417–421[CrossRef]
OpitzB.,
RejaibiA.,
DauberB.,
EckhardJ.,
VinzingM.,
SchmeckB.,
HippenstielS.,
SuttorpN.,
WolffT.2006; IFN β induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 9:930–938
PaladinoP.,
CummingsD. T.,
NoyceR. S.,
MossmanK. L.2006; The IFN-independent response to virus particle entry provides a first line of antiviral defense that is independent of TLRs and retinoic acid-inducible gene I. J Immunol 177:8008–8016[CrossRef]
PalosaariH.,
ParisienJ. P.,
RodriguezJ. J.,
UlaneC. M.,
HorvathC. M.2003; STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J Virol 77:7635–7644[CrossRef]
ParisienJ. P.,
LauJ. F.,
RodriguezJ. J.,
SullivanB. M.,
MosconaA.,
ParksG. D.,
LambR. A.,
HorvathC. M.2001; The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 283:230–239[CrossRef]
ParisienJ. P.,
LauJ. F.,
RodriguezJ. J.,
UlaneC. M.,
HorvathC. M.2002b; Selective STAT protein degradation induced by paramyxoviruses requires both STAT1 and STAT2 but is independent of alpha/beta interferon signal transduction. J Virol 76:4190–4198[CrossRef]
ParkM. S.,
ShawM. L.,
Munoz-JordanJ.,
CrosJ. F.,
NakayaT.,
BouvierN.,
PaleseP.,
Garcia-SastreA.,
BaslerC. F.2003; Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins. J Virol 77:1501–1511[CrossRef]
ParkG. S.,
MorrisK. L.,
HallettR. G.,
BloomM. E.,
BestS. M.2007; Identification of residues critical for the interferon antagonist function of Langat virus NS5 reveals a role for the RNA-dependent RNA polymerase domain. J Virol 81:6936–6946[CrossRef]
PaulusC.,
KraussS.,
NevelsM.2006; A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. Proc Natl Acad Sci U S A 103:3840–3845[CrossRef]
PedersenI. M.,
ChengG.,
WielandS.,
VoliniaS.,
CroceC. M.,
ChisariF. V.,
DavidM.2007; Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 449:919–922[CrossRef]
PerouC. M.,
JeffreyS. S.,
van de RijnM.,
ReesC. A.,
EisenM. B.,
RossD. T.,
PergamenschikovA.,
WilliamsC. F.,
ZhuS. X.other authors1999; Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci U S A 96:9212–9217[CrossRef]
PetersK. L.,
SmithH. L.,
StarkG. R.,
SenG. C.2002; IRF-3-dependent, NF κ B- and JNK-independent activation of the 561 and IFN- β genes in response to double-stranded RNA. Proc Natl Acad Sci U S A 99:6322–6327[CrossRef]
PomerantzJ. L.,
BaltimoreD.1999; NF- κ B activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J 18:6694–6704[CrossRef]
PooleE.,
HeB.,
LambR. A.,
RandallR. E.,
GoodbournS.2002; The V proteins of simian virus 5 and other paramyxoviruses inhibit induction of interferon- β . Virology 303:33–46[CrossRef]
PoppersJ.,
MulveyM.,
KhooD.,
MohrI.2000; Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein. J Virol 74:11215–11221[CrossRef]
PoppersJ.,
MulveyM.,
PerezC.,
KhooD.,
MohrI.2003; Identification of a lytic-cycle Epstein-Barr virus gene product that can regulate PKR activation. J Virol 77:228–236[CrossRef]
PorterF. W.,
BochkovY. A.,
AlbeeA. J.,
WieseC.,
PalmenbergA. C.2006; A picornavirus protein interacts with Ran-GTPase and disrupts nucleocytoplasmic transport. Proc Natl Acad Sci U S A 103:12417–12422[CrossRef]
PowellP. P.,
DixonL. K.,
ParkhouseR. M.1996; An I κ B homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages. J Virol 70:8527–8533
PrakashA.,
SmithE.,
LeeC. K.,
LevyD. E.2005; Tissue-specific positive feedback requirements for production of type I interferon following virus infection. J Biol Chem 280:18651–18657[CrossRef]
PreciousB.,
ChildsK.,
Fitzpatrick-SwallowV.,
GoodbournS.,
RandallR. E.2005a; Simian virus 5 V protein acts as an adaptor, linking DDB1 to STAT2, to facilitate the ubiquitination of STAT1. J Virol 79:13434–13441[CrossRef]
PreciousB.,
YoungD. F.,
AndrejevaL.,
GoodbournS.,
RandallR. E.2005b; In vitro and in vivo specificity of ubiquitination and degradation of STAT1 and STAT2 by the V proteins of the paramyxoviruses simian virus 5 and human parainfluenza virus type 2. J Gen Virol 86:151–158[CrossRef]
PrestonC. M.,
NichollM. J.2006; Role of the cellular protein hDaxx in human cytomegalovirus immediate-early gene expression. J Gen Virol 87:1113–1121[CrossRef]
PrestonC. M.,
HarmanA. N.,
NichollM. J.2001; Activation of interferon response factor-3 in human cells infected with herpes simplex virus type 1 or human cytomegalovirus. J Virol 75:8909–8916[CrossRef]
RalstonS. H.,
AfzalM. A.,
HelfrichM. H.,
FraserW. D.,
GallagherJ. A.,
MeeA.,
RimaB.2007; Multicentre blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget's disease of bone. J Bone Miner Res 22:569–577[CrossRef]
RamaswamyM.,
ShiL.,
MonickM. M.,
HunninghakeG. W.,
LookD. C.2004; Specific inhibition of type I interferon signal transduction by respiratory syncytial virus. Am J Respir Cell Mol Biol 30:893–900[CrossRef]
RamaswamyM.,
ShiL.,
VargaS. M.,
BarikS.,
BehlkeM. A.,
LookD. C.2006; Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology 344:328–339[CrossRef]
RandallG.,
ChenL.,
PanisM.,
FischerA. K.,
LindenbachB. D.,
SunJ.,
HeathcoteJ.,
RiceC. M.,
EdwardsA. M.,
McGilvrayI. D.2006; Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection. Gastroenterology 131:1584–1591[CrossRef]
RaniM. R.,
RansohoffR. M.2005; Alternative and accessory pathways in the regulation of IFN- β -mediated gene expression. J Interferon Cytokine Res 25:788–798[CrossRef]
ReddyS. V.,
MenaaC.,
SingerF. R.,
CundyT.,
CornishJ.,
WhyteM. P.,
RoodmanG. D.1999; Measles virus nucleocapsid transcript expression is not restricted to the osteoclast lineage in patients with Paget's disease of bone. Exp Hematol 27:1528–1532[CrossRef]
RevillaY.,
CallejoM.,
RodriguezJ. M.,
CulebrasE.,
NogalM. L.,
SalasM. L.,
VinuelaE.,
FresnoM.1998; Inhibition of nuclear factor κ B activation by a virus-encoded I κ B-like protein. J Biol Chem 273:5405–5411[CrossRef]
RichtJ. A.,
LekcharoensukP.,
LagerK. M.,
VincentA. L.,
LoiaconoC. M.,
JankeB. H.,
WuW. H.,
YoonK. J.,
WebbyR. J.other authors2006; Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine. J Virol 80:11009–11018[CrossRef]
RimaB. K.,
GassenU.,
HelfrichM. H.,
RalstonS. H.2002; The pro and con of measles virus in Paget's disease: con. J Bone Miner Res 17:2290–2292[CrossRef]
RitchieK. J.,
HahnC. S.,
KimK. I.,
YanM.,
RosarioD.,
LiL.,
de la TorreJ. C.,
ZhangD. E.2004; Role of ISG15 protease UBP43 (USP18) in innate immunity to viral infection. Nat Med 10:1374–1378[CrossRef]
RiveraJ.,
AbramsC.,
HernaezB.,
AlcazarA.,
EscribanoJ. M.,
DixonL.,
AlonsoC.2007; The MyD116 African swine fever virus homologue interacts with the catalytic subunit of protein phosphatase 1 and activates its phosphatase activity. J Virol 81:2923–2929[CrossRef]
RivieccioM. A.,
SuhH. S.,
ZhaoY.,
ZhaoM. L.,
ChinK. C.,
LeeS. C.,
BrosnanC. F.2006; TLR3 ligation activates an antiviral response in human fetal astrocytes: a role for viperin/cig5. J Immunol 177:4735–4741[CrossRef]
RodriguezJ. J.,
ParisienJ. P.,
HorvathC. M.2002; Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J Virol 76:11476–11483[CrossRef]
RoncoL. V.,
KarpovaA. Y.,
VidalM.,
HowleyP. M.1998; Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12:2061–2072[CrossRef]
RouilleY.,
HelleF.,
DelgrangeD.,
RoingeardP.,
VoissetC.,
BlanchardE.,
BelouzardS.,
McKeatingJ.,
PatelA. H.other authors2006; Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J Virol 80:2832–2841[CrossRef]
RuggliN.,
BirdB. H.,
LiuL.,
BauhoferO.,
TratschinJ. D.,
HofmannM. A.2005; Npro of classical swine fever virus is an antagonist of double-stranded RNA-mediated apoptosis and IFN- α / β induction. Virology 340:265–276[CrossRef]
RyzhakovG.,
RandowF.2007; SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J 26:3180–3190[CrossRef]
SaffertR. T.,
KalejtaR. F.2006; Inactivating a cellular intrinsic immune defense mediated by Daxx is the mechanism through which the human cytomegalovirus pp71 protein stimulates viral immediate-early gene expression. J Virol 80:3863–3871[CrossRef]
SaitoT.,
HiraiR.,
LooY. M.,
OwenD.,
JohnsonC. L.,
SinhaS. C.,
AkiraS.,
FujitaT.,
GaleM.Jr2007; Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A 104:582–587[CrossRef]
SakumaR.,
MaelA. A.,
IkedaY.2007; Interferon alpha enhances the TRIM5 α -mediated antiviral activities in human and rhesus monkey cells. J Virol 81:10201–10206[CrossRef]
SasaiM.,
ShingaiM.,
FunamiK.,
YoneyamaM.,
FujitaT.,
MatsumotoM.,
SeyaT.2006; NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J Immunol 177:8676–8683[CrossRef]
SatoM.,
HataN.,
AsagiriM.,
NakayaT.,
TaniguchiT.,
TanakaN.1998; Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett 441:106–110[CrossRef]
SatterlyN.,
TsaiP. L.,
van DeursenJ.,
NussenzveigD. R.,
WangY.,
FariaP. A.,
LevayA.,
LevyD. E.,
FontouraB. M.2007; Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc Natl Acad Sci U S A 104:1853–1858[CrossRef]
SchmidD.,
DengjelJ.,
SchoorO.,
StevanovicS.,
MunzC.2006; Autophagy in innate and adaptive immunity against intracellular pathogens. J Mol Med 84:194–202[CrossRef]
SchoenemeyerA.,
BarnesB. J.,
ManclM. E.,
LatzE.,
GoutagnyN.,
PithaP. M.,
FitzgeraldK. A.,
GolenbockD. T.2005; The interferon regulatory factor, IRF5, is a central mediator of Toll-like receptor 7 signaling. J Biol Chem 280:17005–17012[CrossRef]
SethR. B.,
SunL.,
EaC. K.,
ChenZ. J.2005; Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF- κ B and IRF 3. Cell 122:669–682[CrossRef]
ShabmanR. S.,
MorrisonT. E.,
MooreC.,
WhiteL.,
SutharM. S.,
HuestonL.,
RulliN.,
LidburyB.,
TingJ. P.other authors2007; Differential induction of type I interferon responses in myeloid dendritic cells by mosquito and mammalian-cell-derived alphaviruses. J Virol 81:237–247[CrossRef]
SharmaS.,
tenOeverB. R.,
GrandvauxN.,
ZhouG. P.,
LinR.,
HiscottJ.2003; Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148–1151[CrossRef]
ShawM. L.,
Garcia-SastreA.,
PaleseP.,
BaslerC. F.2004; Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J Virol 78:5633–5641[CrossRef]
ShawM. L.,
CardenasW. B.,
ZamarinD.,
PaleseP.,
BaslerC. F.2005; Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and Toll-like receptor 3-triggered signaling pathways. J Virol 79:6078–6088[CrossRef]
ShinY. K.,
LiuQ.,
TikooS. K.,
BabiukL. A.,
ZhouY.2007; Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J Gen Virol 88:13–18[CrossRef]
SigurdssonS.,
PadyukovL.,
KurreemanF. A.,
LiljedahlU.,
WimanA. C.,
AlfredssonL.,
ToesR.,
RonnelidJ.,
KlareskogL.other authors2007; Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis. Arthritis Rheum 56:2202–2210[CrossRef]
SongB.,
JavanbakhtH.,
PerronM.,
ParkD. H.,
StremlauM.,
SodroskiJ.2005; Retrovirus restriction by TRIM5 α variants from Old World and New World primates. J Virol 79:3930–3937[CrossRef]
SpannK. M.,
TranK. C.,
CollinsP. L.2005; Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF- κ B, and proinflammatory cytokines. J Virol 79:5353–5362[CrossRef]
SpiegelM.,
PichlmairA.,
Martinez-SobridoL.,
CrosJ.,
Garcia-SastreA.,
HallerO.,
WeberF.2005; Inhibition of beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. J Virol 79:2079–2086[CrossRef]
SpiropoulouC. F.,
AlbarinoC. G.,
KsiazekT. G.,
RollinP. E.2007; Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can downregulate interferon signaling. J Virol 81:2769–2776[CrossRef]
SpitkovskyD.,
HehnerS. P.,
HofmannT. G.,
MollerA.,
SchmitzM. L.2002; The human papillomavirus oncoprotein E7 attenuates NF- κ B activation by targeting the I κ B kinase complex. J Biol Chem 277:25576–25582[CrossRef]
SrivastavaS. P.,
KumarK. U.,
KaufmanR. J.1998; Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase. J Biol Chem 273:2416–2423[CrossRef]
StackJ.,
HagaI. R.,
SchroderM.,
BartlettN. W.,
MaloneyG.,
ReadingP. C.,
FitzgeraldK. A.,
SmithG. L.,
BowieA. G.2005; Vaccinia virus protein A46R targets multiple Toll-like-interleukin-1 receptor adaptors and contributes to virulence. J Exp Med 201:1007–1018[CrossRef]
StancatoL. F.,
DavidM.,
Carter-SuC.,
LarnerA. C.,
PrattW. B.1996; Preassociation of STAT1 with STAT2 and STAT3 in separate signalling complexes prior to cytokine stimulation. J Biol Chem 271:4134–4137[CrossRef]
StockN.,
GoodbournS.,
RandallR. E.2005; The anti-interferon mechanisms of paramyxoviruses. In Modulation of Host Gene Expression and Innate Immunity by Viruses pp 115–139Edited byPalese.
New York: Springer;
StojdlD. F.,
LichtyB.,
KnowlesS.,
MariusR.,
AtkinsH.,
SonenbergN.,
BellJ. C.2000; Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. Nat Med 6:821–825[CrossRef]
StojdlD. F.,
LichtyB. D.,
tenOeverB. R.,
PatersonJ. M.,
PowerA. T.,
KnowlesS.,
MariusR.,
ReynardJ.,
PoliquinL.other authors2003; VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 4:263–275[CrossRef]
StrackerT. H.,
LeeD. V.,
CarsonC. T.,
AraujoF. D.,
OrnellesD. A.,
WeitzmanM. D.2005; Serotype-specific reorganization of the Mre11 complex by adenoviral E4orf3 proteins. J Virol 79:6664–6673[CrossRef]
StrahleL.,
MarqJ.-B.,
BriniA.,
HausmannS.,
KolakofskyD.,
GarcinD.2007; Activation of the IFN β promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by the viral C proteins. J Virol in press
StremlauM.,
OwensC. M.,
PerronM. J.,
KiesslingM.,
AutissierP.,
SodroskiJ.2004; The cytoplasmic body component TRIM5 α restricts HIV-1 infection in Old World monkeys. Nature 427:848–853[CrossRef]
SunQ.,
SunL.,
LiuH. H.,
ChenX.,
SethR. B.,
FormanJ.,
ChenZ. J.2006; The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24:633–642[CrossRef]
SymonsJ. A.,
AlcamiA.,
SmithG. L.1995; Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81:551–560[CrossRef]
TabetaK.,
GeorgelP.,
JanssenE.,
DuX.,
HoebeK.,
CrozatK.,
MuddS.,
ShamelL.,
SovathS.other authors2004; Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A 101:3516–3521[CrossRef]
TaitS. W.,
ReidE. B.,
GreavesD. R.,
WilemanT. E.,
PowellP. P.2000; Mechanism of inactivation of NF- κ B by a viral homologue of I κ B α . Signal-induced release of I κ B α results in binding of the viral homologue to NF- κ B. J Biol Chem 275:34656–34664[CrossRef]
TakaokaA.,
YanaiH.,
KondoS.,
DuncanG.,
NegishiH.,
MizutaniT.,
KanoS.,
HondaK.,
OhbaY.other authors2005; Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434:243–249[CrossRef]
TakaokaA.,
WangZ.,
ChoiM. K.,
YanaiH.,
NegishiH.,
BanT.,
LuY.,
MiyagishiM.,
KodamaT.other authors2007; DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature 448:501–505[CrossRef]
TakayanagiH.,
KimS.,
TaniguchiT.2002; Signaling crosstalk between RANKL and interferons in osteoclast differentiation. Arthritis Res 4:Suppl. 3S227–S232[CrossRef]
TakayanagiH.,
SatoK.,
TakaokaA.,
TaniguchiT.2005; Interplay between interferon and other cytokine systems in bone metabolism. Immunol Rev 208:181–193[CrossRef]
TakeuchiK.,
KadotaS. I.,
TakedaM.,
MiyajimaN.,
NagataK.2003; Measles virus V protein blocks interferon (IFN)- α / β but not IFN- γ signaling by inhibiting STAT1 and STAT2 phosphorylation. FEBS Lett 545:177–182[CrossRef]
TalloczyZ.,
JiangW.,
VirginH. W.IV,
LeibD. A.,
ScheunerD.,
KaufmanR. J.,
EskelinenE. L.,
LevineB.2002; Regulation of starvation- and virus-induced autophagy by the eIF2 α kinase signaling pathway. Proc Natl Acad Sci U S A 99:190–195[CrossRef]
TalonJ.,
HorvathC. M.,
PolleyR.,
BaslerC. F.,
MusterT.,
PaleseP.,
Garcia-SastreA.2000a; Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol 74:7989–7996[CrossRef]
TalonJ.,
SalvatoreM.,
O'NeillR. E.,
NakayaY.,
ZhengH.,
MusterT.,
Garcia-SastreA.,
PaleseP.2000b; Influenza A and B viruses expressing altered NS1 proteins: a vaccine approach. Proc Natl Acad Sci U S A 97:4309–4314[CrossRef]
TanS. L.,
KatzeM. G.1998; Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J Interferon Cytokine Res 18:757–766[CrossRef]
TangX.,
GaoJ. S.,
GuanY. J.,
McLaneK. E.,
YuanZ. L.,
RamratnamB.,
ChinY. E.2007; Acetylation-dependent signal transduction for type I interferon receptor. Cell 131:93–105[CrossRef]
TengM. N.,
WhiteheadS. S.,
BerminghamA.,
St ClaireM.,
ElkinsW. R.,
MurphyB. R.,
CollinsP. L.2000; Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees. J Virol 74:9317–9321[CrossRef]
tenOeverB. R.,
ServantM. J.,
GrandvauxN.,
LinR.,
HiscottJ.2002; Recognition of the measles virus nucleocapsid as a mechanism of IRF-3 activation. J Virol 76:3659–3669[CrossRef]
tenOeverB. R.,
NgS. L.,
ChuaM. A.,
McWhirterS. M.,
Garcia-SastreA.,
ManiatisT.2007; Multiple functions of the IKK-related kinase IKKϵ in interferon-mediated antiviral immunity. Science 315:1274–1278[CrossRef]
TerenziF.,
PalS.,
SenG. C.2005; Induction and mode of action of the viral stress-inducible murine proteins, P56 and P54. Virology 340:116–124[CrossRef]
ThomasD.,
BlakqoriG.,
WagnerV.,
BanholzerM.,
KesslerN.,
ElliottR. M.,
HallerO.,
WeberF.2004; Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist. J Biol Chem 279:31471–31477[CrossRef]
TothA. M.,
ZhangP.,
DasS.,
GeorgeC. X.,
SamuelC. E.2006; Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase. Prog Nucleic Acid Res Mol Biol 81:369–434
ToughD. F.,
BorrowP.,
SprentJ.1996; Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272:1947–1950[CrossRef]
UddinS.,
SassanoA.,
DebD. K.,
VermaA.,
MajchrzakB.,
RahmanA.,
MalikA. B.,
FishE. N.,
PlataniasL. C.2002; Protein kinase C- δ (PKC- δ ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727. J Biol Chem 277:14408–14416[CrossRef]
UlaneC. M.,
HorvathC. M.2002; Paramyxoviruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 304:160–166[CrossRef]
UlaneC. M.,
KentsisA.,
CruzC. D.,
ParisienJ. P.,
SchneiderK. L.,
HorvathC. M.2005; Composition and assembly of STAT-targeting ubiquitin ligase complexes: paramyxovirus V protein carboxyl terminus is an oligomerization domain. J Virol 79:10180–10189[CrossRef]
UnterstabG.,
LudwigS.,
AntonA.,
PlanzO.,
DauberB.,
KrappmannD.,
HeinsG.,
EhrhardtC.,
WolffT.2005; Viral targeting of the interferon- β -inducing Traf family member-associated NF- κ B activator (TANK)-binding kinase-1. Proc Natl Acad Sci U S A 102:13640–13645[CrossRef]
UsachevaA.,
SmithR.,
MinshallR.,
BaidaG.,
SengS.,
CrozeE.,
ColamoniciO.2001; The WD motif-containing protein receptor for activated protein kinase C (RACK1) is required for recruitment and activation of signal transducer and activator of transcription 1 through the type I interferon receptor. J Biol Chem 276:22948–22953[CrossRef]
ValarcherJ. F.,
FurzeJ.,
WyldS.,
CookR.,
ConzelmannK. K.,
TaylorG.2003; Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins. J Virol 77:8426–8439[CrossRef]
ValchanovaR. S.,
Picard-MaureauM.,
BudtM.,
BruneW.2006; Murine cytomegalovirus m142 and m143 are both required to block protein kinase R-mediated shutdown of protein synthesis. J Virol 80:10181–10190[CrossRef]
van Boxel-DezaireA. H.,
RaniM. R.,
StarkG. R.2006; Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25:361–372[CrossRef]
Van CleveW.,
Amaro-CarambotE.,
SurmanS. R.,
BekiszJ.,
CollinsP. L.,
ZoonK. C.,
MurphyB. R.,
SkiadopoulosM. H.,
BartlettE. J.2006; Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1. Virology 352:61–73[CrossRef]
van PeschV.,
van EyllO.,
MichielsT.2001; The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production. J Virol 75:7811–7817[CrossRef]
VidyA.,
El BougriniJ.,
Chelbi-AlixM. K.,
BlondelD.2007; The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J Virol 81:4255–4263[CrossRef]
WangX.,
LiM.,
ZhengH.,
MusterT.,
PaleseP.,
BegA. A.,
Garcia-SastreA.2000; Influenza A virus NS1 protein prevents activation of NF- κ B and induction of alpha/beta interferon. J Virol 74:11566–11573[CrossRef]
WangF.,
MaY.,
BarrettJ. W.,
GaoX.,
LohJ.,
BartonE.,
VirginH. W.,
McFaddenG.2004; Disruption of Erk-dependent type I interferon induction breaks the myxoma virus species barrier. Nat Immunol 5:1266–1274[CrossRef]
WangX.,
HinsonE. R.,
CresswellP.2007; The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2:96–105[CrossRef]
WeberF.,
BridgenA.,
FazakerleyJ. K.,
StreitenfeldH.,
KesslerN.,
RandallR. E.,
ElliottR. M.2002; Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. J Virol 76:7949–7955[CrossRef]
WeberF.,
WagnerV.,
RasmussenS. B.,
HartmannR.,
PaludanS. R.2006; Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 80:5059–5064[CrossRef]
WeihuaX.,
RamanujamS.,
LindnerD. J.,
KudaravalliR. D.,
FreundR.,
KalvakolanuD. V.1998; The polyoma virus T antigen interferes with interferon-inducible gene expression. Proc Natl Acad Sci U S A 95:1085–1090[CrossRef]
WhitlowZ. W.,
ConnorJ. H.,
LylesD. S.2006; Preferential translation of vesicular stomatitis virus mRNAs is conferred by transcription from the viral genome. J Virol 80:11733–11742[CrossRef]
WhittenT. M.,
QuetsA. T.,
SchloemerR. H.1991; Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene. J Virol 65:4699–4704
WindischM. P.,
FreseM.,
KaulA.,
TripplerM.,
LohmannV.,
BartenschlagerR.2005; Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line. J Virol 79:13778–13793[CrossRef]
WollmannG.,
RobekM. D.,
van den PolA. N.2007; Variable deficiencies in the interferon response enhance susceptibility to vesicular stomatitis virus oncolytic actions in glioblastoma cells but not in normal human glial cells. J Virol 81:1479–1491[CrossRef]
WrightP. F.,
KarronR. A.,
MadhiS. A.,
TreanorJ. J.,
KingJ. C.,
O'SheaA.,
IkizlerM. R.,
ZhuY.,
CollinsP. L.other authors2006; The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans. J Infect Dis 193:573–581[CrossRef]
WuC. J.,
ConzeD. B.,
LiT.,
SrinivasulaS. M.,
AshwellJ. D.2006; Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF- κ B activation. Nat Cell Biol 8:398–406[CrossRef]
XuL. G.,
WangY. Y.,
HanK. J.,
LiL. Y.,
ZhaiZ.,
ShuH. B.2005; VISA is an adapter protein required for virus-triggered IFN- β signaling. Mol Cell 19:727–740[CrossRef]
XuD.,
BrummK.,
ZhangL.2006; The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production. J Biol Chem 281:9163–9169[CrossRef]
YalamanchiliP.,
HarrisK.,
WimmerE.,
DasguptaA.1996; Inhibition of basal transcription by poliovirus: a virus-encoded protease (3Cpro) inhibits formation of TBP-TATA box complex in vitro. J Virol 70:2922–2929
YanaiH.,
ChenH. M.,
InuzukaT.,
KondoS.,
MakT. W.,
TakaokaA.,
HondaK.,
TaniguchiT.2007; Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc Natl Acad Sci U S A 104:3402–3407[CrossRef]
YangH.,
MaG.,
LinC. H.,
OrrM.,
WatheletM. G.2004; Mechanism for transcriptional synergy between interferon regulatory factor (IRF)-3 and IRF-7 in activation of the interferon-β gene promoter. Eur J Biochem 271:3693–3703[CrossRef]
YapM. W.,
NisoleS.,
LynchC.,
StoyeJ. P.2004; Trim5 α protein restricts both HIV-1 and murine leukemia virus. Proc Natl Acad Sci U S A 101:10786–10791[CrossRef]
YasudaK.,
RichezC.,
MaciaszekJ. W.,
AgrawalN.,
AkiraS.,
Marshak-RothsteinA.,
RifkinI. R.2007; Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production. J Immunol 178:6876–6885[CrossRef]
YeowW. S.,
AuW. C.,
JuangY. T.,
FieldsC. D.,
DentC. L.,
GewertD. R.,
PithaP. M.2000; Reconstitution of virus-mediated expression of interferon α genes in human fibroblast cells by ectopic interferon regulatory factor-7. J Biol Chem 275:6313–6320[CrossRef]
YokotaS.,
SaitoH.,
KubotaT.,
YokosawaN.,
AmanoK.,
FujiiN.2003; Measles virus suppresses interferon- α signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon- α receptor complex. Virology 306:135–146[CrossRef]
YokotaS.,
YokosawaN.,
OkabayashiT.,
SuzutaniT.,
MiuraS.,
JimbowK.,
FujiiN.2004; Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J Virol 78:6282–6286[CrossRef]
YoneyamaM.,
KikuchiM.,
MatsumotoK.,
ImaizumiT.,
MiyagishiM.,
TairaK.,
FoyE.,
LooY. M.,
GaleM.Jrother authors2005; Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175:2851–2858[CrossRef]
YoungD. F.,
RandallR. E.,
HoyleJ. A.,
SouberbielleB. E.1990; Clearance of a persistent paramyxovirus infection is mediated by cellular immune responses but not by serum-neutralizing antibody. J Virol 64:5403–5411
YoungD. F.,
ChatziandreouN.,
HeB.,
GoodbournS.,
LambR. A.,
RandallR. E.2001; Single amino acid substitution in the V protein of simian virus 5 differentiates its ability to block interferon signaling in human and murine cells. J Virol 75:3363–3370[CrossRef]
YoungD. F.,
AndrejevaL.,
LivingstoneA.,
GoodbournS.,
LambR. A.,
CollinsP. L.,
ElliottR. M.,
RandallR. E.2003; Virus replication in engineered human cells that do not respond to interferons. J Virol 77:2174–2181[CrossRef]
YuanW.,
KrugR. M.2001; Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J 20:362–371[CrossRef]
YuanH.,
YozaB. K.,
LylesD. S.1998; Inhibition of host RNA polymerase II-dependent transcription by vesicular stomatitis virus results from inactivation of TFIID. Virology 251:383–392[CrossRef]
ZahnR. C.,
SchelpI.,
UtermohlenO.,
von LaerD.2007; A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus. J Virol 81:457–464[CrossRef]
ZhangP.,
SamuelC. E.2007; Protein kinase PKR plays a stimulus- and virus-dependent role in apoptotic death and virus multiplication in human cells. J Virol 81:8192–8200[CrossRef]
ZhangJ. J.,
VinkemeierU.,
GuW.,
ChakravartiD.,
HorvathC. M.,
DarnellJ. E.Jr1996; Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. Proc Natl Acad Sci U S A 93:15092–15096[CrossRef]
ZhangJ.,
DasS. C.,
KotalikC.,
PattnaikA. K.,
ZhangL.2004; The latent membrane protein 1 of Epstein-Barr virus establishes an antiviral state via induction of interferon-stimulated genes. J Biol Chem 279:46335–46342[CrossRef]
ZhangY.,
BurkeC. W.,
RymanK. D.,
KlimstraW. B.2007; Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J Virol 81:11246–11255[CrossRef]
ZhaoC.,
DenisonC.,
HuibregtseJ. M.,
GygiS.,
KrugR. M.2005; Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A 102:10200–10205[CrossRef]
ZhouZ.,
HammingO. J.,
AnkN.,
PaludanS. R.,
NielsenA. L.,
HartmannR.2007; Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases. J Virol 81:7749–7758[CrossRef]
ZouW.,
KimJ. H.,
HandiduA.,
LiX.,
KimK. I.,
YanM.,
LiJ.,
ZhangD. E.2007; Microarray analysis reveals that type I interferon strongly increases the expression of immune-response related genes in Ubp43 (Usp18) deficient macrophages. Biochem Biophys Res Commun 356:193–199[CrossRef]